Abstract:Background and objectives: Rifampicin (RIF) and isoniazid (INH), two most potent antibiotics, are prescribed to cure tuberculosis. Mycobacterium tuberculosis, the causative agent of multidrug-resistant tuberculosis (MDR-TB), is resistant to these first-line drugs. Here, two molecular techniques were demonstrated such as PCR sequencing-based and GeneXpert assay for rapidly identifying MDR-TB. Materials and methods: Pulmonary samples (sputum) were collected from 55 MDR-TB suspected patients from the National Tuberculosis Reference Laboratory (NTRL), Dhaka where the research work was partially accomplished and continued in the department of Microbiology, University of Dhaka, Bangladesh. We strived for sequencing technique as well as GeneXpert assay to identify mutations in rpoB and katG genes in MTB strains and sputum directly. Culture-based drug susceptibility testing (DST) was performed to measure the efficacy of the molecular methods employed. Results: When analyzed, rpoB gene mutations at codons 531 (54.54%), 526 (14.54%), and 516 (10.91%) were found by sequencing in 80% of the samples. Nucleotide substitution at katG315 (AGC→ACC) was spotted in 16 (76.19%) out of 21 samples. When comparing the sequencing results with DST, sensitivity and specificity were investigated to determine drug-resistance (rifampicin-resistance were 98 and 100% whereas isoniazid-resistance were 94 and 100% respectively). Additionally, as a point of comparison with DST, only 85.45% of RIF mono-resistant TB cases were accurately evaluated by the GeneXpert assay. Conclusion: This research supports the adoption of PCR sequencing approach as an efficient tool in detecting MDR-TB, counting the higher sensitivity and specificity as well as the short period to produce the results.

Characterization and Rapid Detection of Mutations in rpoB,KatG Gene of Clinical Isolates Mycobacterium bovis

Mutation Analysis on rpsL,rpoB,KatG Gene of Clinical Isolates Mycobacterium bovis

Establishment and Application of Multi-Pcr-sscp Assay for Rapid Detection of Isoniazid- and Rifampin-Resistance Mycobacterium Tuberculosis Isolates

Cows Mycobacterium Tuberculosis Rpob and Katg Gene Mutations Associated with Multi-drug Resistance

Detection of the isoniazid-resistant katG gene of Mycobacterium tuberculosis

Rapid Detecting Mycobacterium Tuberculosis of Multiple Drug Resistance by The Molecular Biologic Technique

Rapid Detection of Rpob Gene Mutations in Rif-Resistant M. Tuberculosis Isolates by Oligonucleotide Microarray.

Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray: Detection of resistance genes in M. tuberculosis

Rapid detecting a point mutation of the Mycobacterium tuberculosis catalase-peroxidase ( katG ) gene associated with isoniazid resistance

Study on Rpob Gene Mutations in Mycobacterium Tuberculosis

Study on rpoB mutation in rifampin resistants mycobacterium tuberculosis

Characterization and Rapid Detection of Mutations in RpoB Gene of Rifampin-Resistant Mycobacterium Tuberculosis Strains

Rapid detection of mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis by oligonucleotide microarray

Identification of Drug-resistance Gene Type in Mycobacterium Tuberculosis by PCR-oligonucleotide Microchips

Evaluation of Pyrosequencing for the Detection of Rpob Gene Mutation in Mycobacterium Tuberculosis

Study of the mutation characteristics of rifampicin-resistance gene (rpoB) in 210 clinical isolates of M. tuberculosis

Multi-drug resistant gene mutation analysis in Mycobacterium tuberculosis by molecular techniques

Rapid Detection of Gene Mutation in Multiple-Drug Resistant Mycobacterium Tuberculosis by PCR and Single-Strand Conformation Polymorphism Analysis

rpoB Gene Mutations in 55 Mycobacterium Tuberculosis Clinical Isolates

Relativity of Rpob Gene Mutations in Mycobacterium Tuberculosis,Multi-drug Resistance and Degree of Resistance to Rifampin

Molecular Analysis of Rpob Gene Mutations of Rifampin-Resistant Mycobacterium Tuberculosis Clinical Isolates in Xi'an City